UBS Group AG - LUMOS PHARMA INC ownership

LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 39 filers reported holding LUMOS PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of LUMOS PHARMA INC
ValueSharesWeighting
Q4 2022$7,339
+22.3%
2,033
+174.0%
0.00%
Q3 2022$6,000
-60.0%
742
-61.7%
0.00%
Q2 2022$15,000
-25.0%
1,936
-8.8%
0.00%
Q1 2022$20,000
-48.7%
2,122
-62.1%
0.00%
Q4 2021$39,000
+875.0%
5,594
+1082.7%
0.00%
Q3 2021$4,000
+300.0%
473
+326.1%
0.00%
Q2 2021$1,000
-93.3%
111
-91.7%
0.00%
Q1 2021$15,000
-55.9%
1,337
+41.9%
0.00%
Q4 2020$34,000
+47.8%
942
-41.3%
0.00%
Q3 2020$23,000
+1050.0%
1,604
+1345.0%
0.00%
Q2 2020$2,000
-81.8%
111
-91.3%
0.00%
Q1 2020$11,0001,2760.00%
Other shareholders
LUMOS PHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
PVG ASSET MANAGEMENT CORP 10,175$70,512,0000.26%
Minerva Advisors LLC 34,015$236,0000.14%
Investors Financial Group, LLC 30,600$212,0000.10%
Lion Point Capital, LP 51,205$354,0000.10%
NEA Management Company, LLC 376,916$2,612,0000.05%
Wealth Advisors of Iowa, LLC 11,699$81,0000.04%
Paladin Advisory Group, LLC 4,382$30,0000.02%
Marquette Asset Management, LLC 13,315$92,0000.02%
Blackstone Inc. 468,145$3,244,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 47,643$331,0000.01%
View complete list of LUMOS PHARMA INC shareholders